Singh, S.K. and Tyagi, R.K. 2018. Thiazolidinedione Class of Anti-Diabetic Drugs Modulate Nuclear Receptor CAR Function. Journal of Endocrinology and Reproduction. 21, 1 (Aug. 2018), 27–34.